CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 366 enrolled
Drug / intervention
CyberSengabehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00906178
NCT00906178Phase 1Completed
CompareCT.gov

CyberSenga: Harnessing the Power of the Internet to Prevent HIV in Ugandan Youth

Center for Innovative Public Health Research·interventional·Posted May 21, 2009·Updated Aug 11, 2016

In Brief

A Phase 1 clinical trial evaluating CyberSenga for Sexual Abstinence and Condom Use. Completed, enrolled 366 participants across 1 site.

Detailed Summary

The investigators propose to design and test an Internet-based HIV prevention program for adolescents in Uganda.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSexual Abstinence, Condom Use
CountriesUganda
CollaboratorsMbarara University of Science and Technology, Harvard University, University of Colorado, Denver, Internet Solutions for Kids Uganda, Limited, National Institute of Mental Health (NIMH)

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 21, 2009
Enrollment StartAug 1, 2007
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 17.1 years ago

Interventions

CyberSengabehavioral

Internet-based HIV prevention program